Evidence map›Paper›PMID 36738311›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.

M Grahovac, C P Spielvogel, D Krajnc, B Ecsedi, T Traub-Weidinger, S Rasul, K Kluge, M Zhao, X Li, M Hacker and 2 more

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Machine Learning-Driven radiomics on 18 F-FDG PET for glioma diagnosis: a systematic review and meta-analysis.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Error mitigation enables PET radiomic cancer characterization on quantum computers.European journal of nuclear medicine and molecular imaging · 2023
    Article
  6. Article
  7. "Fuzzy" radiomics: the way forward for nuclear medicine imaging applications?European journal of nuclear medicine and molecular imaging · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

M GrahovacDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
C P SpielvogelDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
D KrajncCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20, AT-1090, Vienna, Austria.
B EcsediCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20, AT-1090, Vienna, Austria.
T Traub-WeidingerDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
S RasulDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
K KlugeDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
M ZhaoDepartment of Nuclear Medicine, Peking University Third Hospital, Beijing, People's Republic of China.
X LiDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
M HackerDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
A HaugDivision of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
Laszlo PappCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Waehringer Guertel 18-20, AT-1090, Vienna, Austria. laszlo.papp@meduniwien.ac.at.ORCID 0000-0002-9049-9989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHybrid imaging became an instrumental part of medical imaging, particularly cancer imaging processes in clinical routine. To date, several radiomic and machine learning studies investigated the feasibility of in vivo tumor characterization with variable outcomes. This study aims to investigate the effect of recently proposed fuzzy radiomics and compare its predictive performance to conventional radiomics in cancer imaging cohorts. In addition, lesion vs. lesion+surrounding fuzzy and conventional radiomic analysis was conducted.

methodsPreviously published 11C Methionine (MET) positron emission tomography (PET) glioma, 18F-FDG PET/computed tomography (CT) lung, and 68GA-PSMA-11 PET/magneto-resonance imaging (MRI) prostate cancer retrospective cohorts were included in the analysis to predict their respective clinical endpoints. Four delineation methods including manually defined reference binary (Ref-B), its smoothed, fuzzified version (Ref-F), as well as extended binary (Ext-B) and its fuzzified version (Ext-F) were incorporated to extract imaging biomarker standardization initiative (IBSI)-conform radiomic features from each cohort. Machine learning for the four delineation approaches was performed utilizing a Monte Carlo cross-validation scheme to estimate the predictive performance of the four delineation methods.

resultsReference fuzzy (Ref-F) delineation outperformed its binary delineation (Ref-B) counterpart in all cohorts within a volume range of 938-354987 mm

conclusionsFuzzy radiomics has the potential to increase predictive performance particularly in small lesion sizes compared to conventional binary radiomics in PET. We hypothesize that this effect is due to the ability of fuzzy radiomics to model partial volume effects and delineation uncertainties at small lesion boundaries. In addition, we consider that the lower redundancy of fuzzy radiomic features supports the identification of imaging biomarkers in future studies. Future studies shall consider systematically analyzing lesions and their surroundings with fuzzy and binary radiomics.

Indexed as

GliomaProstatic NeoplasmsFluorodeoxyglucose F18HumansMachine LearningMalePositron-Emission TomographyPositron Emission Tomography Computed TomographyRetrospective StudiesFluorodeoxyglucose F18Fuzzy radiomicsMachine learningPETPET/CTPET/MRIRadiomics

Identifiers

PMID36738311
PMCPMC10119059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.